Small cell lung cancer accounts for about 15 percent of all diagnosed lung cancers and is still associated with a high mortality rate. SCLC tumours often develop resistance to chemotherapy and thus poor prognosis is due to tumour recurrence which occurs within only five to 14 months after initial diagnosis. As a recent research study led by Balazs Döme and Karin Schelch from MedUni Vienna shows, resistant cell lines can be successfully fought with a combination of two already available therapeutic agents. The study results were published in the medical journal "Clinical Cancer Research" and offer a promising approach for the development of new therapies for this particularly aggressive type of tumour.
In the summer of 2022, one of Tyrol's largest glaciers recorded its largest mass loss ever. The Hintereisferner in the Ötztal valley reached its Glacier Loss Day (GLD) earlier than ever before. GLD serves as an indicator of a glacier's health over the course of the year, similar to how Earth Overshoot Day measures the Earth's resource consumption. A team of glacier researchers led by Annelies Voordendag at the Institute of Atmospheric and Cryospheric Sciences at the University of Innsbruck is using state-of-the-art laser scanning techniques to determine GLD.
Autoimmune diseases are complex conditions whose causes are diverse and have not been fully elucidated to date. A research team at MedUni Vienna has now discovered an immunoregulatory protein that could be linked to the development of autoimmune diseases such as rheumatoid arthritis. -Rinl- is the name of the identified building block of the immune system, which may provide a new starting point for the development of immunomodulatory therapies. The study results were recently published in the Journal of Experimental Medicine.
Autoimmune diseases are complex illnesses, the causes of which are diverse and have not yet been fully explained. A research team at MedUni Vienna has now discovered an immunoregulatory protein that could be linked to the development of autoimmune diseases such as rheumatoid arthritis. The identified component of the immune system is called "Rinl", which could provide a new target for the development of immunomodulatory therapies. The study results were recently published in the Journal of Experimental Medicine.
PostDoc (gn*) University Hospital in Muenster
Professor of Information Systems and Business Process Management (Open Rank) Universität Liechtenstein
Professor für Entrepreneurship und Strategisches Management (Open Rank) (m/w/d) Universität Liechtenstein
Gruppenleiter (gn*) Neuroinflammation Universitätsklinikum Münster (UKM)
Wissenschaftlicher Mitarbeiter (m/w/d) DRK-Blutspendedienst NSTOB gGmbH, Springe
Getzner endows new professorship for railroad construction
Storing hydrogen in small, red iron pellets
Golden future for thermoelectrics
Gerhard Prager takes over presidency of IFSO
Patient Safety Day: Experts inform about drug therapy safety, hand hygiene and child resuscitation
Jing Ning honored with WIMIN Scholar Award
'A battery is a diary of driving behaviour.'
'We have to make the urban water cycle close to nature again'
'For me research is a great playground'
ERC Grant for Biodiversity Research